PATENT CLAIM ANALYSIS

Application Number: 16206448
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "186100"]

Abstract:
The present invention provides recombinant adenoviral compositions and methods for their use in treating disorders associated with epithelial tissues.

Claim (Index 13):
The recombinant AdB-2/3 fiber polypeptide of  claim 7 , wherein the polypeptide comprises a homotrimer.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 98.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15593578', '14429803', '13158246', '14066353', '15538975']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7900452528056171
- 35 USC 102 Novelty (BERT): 0.7179172975210878
- Combined Prediction Score: 0.7828324572771642
- Mean Citation Score: 620.776718
- Max Citation Score: 795.7945599999997
- Similarity Product: 749.4706349934006

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test